HLA-A anticorps (PerCP)

N° du produit ABIN2659889

Cet anticorps anti-HLA-A Monoclonal Souris conjugué à PerCP (Clone W6-32) (ABIN2659889) détecte spécifiquement HLA-A dans FACS. L’anticorps est réactif avec des échantillons de Humain, Cynomolgus et Macaque rhésus.

Aperçu rapide pour HLA-A anticorps (PerCP) (ABIN2659889)

Antigène: HLA-A (Major Histocompatibility Complex, Class I, A (HLA-A))

Reactivité: Humain, Cynomolgus, Macaque rhésus

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp HLA-A est conjugé à/à la PerCP

Application: Flow Cytometry (FACS)

Clone: W6-32

Détail du produit anti-HLA-A anticorps (PerCP)

Réactivité croisée: Chimpanzé, Babouin, Cynomolgus, Macaque rhésus, Boeuf (Vache), Chat

Purification: The antibody was purified by affinity chromatography, and conjugated with PerCP under optimal conditions. The solution is free of unconjugated PerCP and unconjugated antibody.

Isotype: IgG2a kappa

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Buffer: Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide and 0.2 % (w/v) BSA .

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Protect from prolonged exposure to light. Do not freeze.

Stock: 4 °C

Stockage commentaire: The antibody solution should be stored undiluted between 2°C and 8°C.

Détails sur HLA-A

Antigène: HLA-A (Major Histocompatibility Complex, Class I, A (HLA-A))

Autre désignation: HLA-A

Sujet: MHC class I antigens associated with β2-microglobulin are expressed by all human nucleated cells. MHC class I molecules are involved in presentation of antigens to CD8+ T cells. They play an important role in cell-mediated immune responses and tumor surveillance.

Pathways: TCR Signaling, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response